Real-World Insurance Claims Analysis of Venous Thromboembolism in Japanese Patients with Inflammatory Bowel Disease.

"Declarations Conflict of interestM.F. has received grants from Fuji Chemical Industries Co., Ltd., JIMRO Co., Ltd., Kamui Pharma Inc., Nobelpharma Co., Ltd., and Yakult Honsha Co., Ltd.; grants and personal fees from AbbVie Inc, AYUMI Pharmaceutical Corporation, Bristol-Myers Squibb, Daiichi Sankyo Co., Ltd., EA Pharma Co., Ltd., Janssen Pharmaceutical K.K., Kyorin Pharmaceutical Co., Ltd., Mitsubishi Tanabe Pharma Corporation, Mochida Pharmaceutical Co., Ltd., Nippon Kayaku Co., Ltd., Pfizer Inc, Takeda Pharmaceutical Co., Ltd., and ZERIA Pharmaceutical Co., Ltd.; and personal fees from Aspen Japan K.K., AstraZeneca.co.jp, Boehringer Ingelheim GmbH, Celltrion Healthcare Japan Co., Ltd., Chugai Pharmaceutical Co., Ltd., Horii Pharmaceutical Ind., Ltd., Kissei Pharmaceutical Co., Ltd., Medical Tribune, Inc., Nobelpharma Co., Ltd., Olympus Co., Ltd., Sanofi K.K., Shionogi & Co., Ltd., Taiho Pharmaceutical Co., Ltd., Technical Information Institute Co., Ltd., and Teijin Pharma Ltd. T.K. is a former employee and stockholder of Pfizer Inc, and is a current employee of Eli Lilly and Company. S.A., S.H., F.M., and S.Y. are employees and stockholders of Pfizer Inc. N.I. and N.Y. are former employees and stockholders of Pfizer Inc. M.N. has received lecture fees from Daiichi Sankyo Co., Ltd. K.M. has received grants and personal fees from AbbVie Inc, EA Pharma Co., Ltd., Kissei Pharmaceutical Co., Ltd., Kyorin Pharmaceutical Co., Ltd., Mitsubishi Tanabe Pharma Corporation, Mochida Pharmaceutical Co., Ltd., Nipponn Kayaku Co., Ltd., Pfizer Inc, Sekisui Medical Co., Ltd., Takeda Pharmaceutical Co., Ltd.; and personal fees from Alfresa Pharma Corporation, Gilead Sciences, Inc., GlaxoSmithKline plc, Janssen Pharmaceutical K.K., JIMRO Co., Ltd., MIYARISAN Pharmaceutical Co., Ltd., Thermo Fisher Scientific Inc., and ZERIA Pharmaceutical Co., Ltd. Conflict of interest M.F. has received grants from Fuji Chemical Industries Co., Ltd., JIMRO Co., Ltd., Kamui Pharma Inc., Nobelpharma Co., Ltd., and Yakult Honsha Co., Ltd.; grants and personal fees from AbbVie Inc, AYUMI Pharmaceutical Corporation, Bristol-Myers Squibb, Daiichi Sankyo Co., Ltd., EA Pharma Co., Ltd., Janssen Pharmaceutical K.K., Kyorin Pharmaceutical Co., Ltd., Mitsubishi Tanabe Pharma Corporation, Mochida Pharmaceutical Co., Ltd., Nippon Kayaku Co., Ltd., Pfizer Inc, Takeda Pharmaceutical Co., Ltd., and ZERIA Pharmaceutical Co., Ltd.; and personal fees from Aspen Japan K.K., AstraZeneca.co.jp, Boehringer Ingelheim GmbH, Celltrion Healthcare Japan Co., Ltd., Chugai Pharmaceutical Co., Ltd., Horii Pharmaceutical Ind., Ltd., Kissei Pharmaceutical Co., Ltd., Medical Tribune, Inc., Nobelpharma Co., Ltd., Olympus Co., Ltd., Sanofi K.K., Shionogi & Co., Ltd., Taiho Pharmaceutical Co., Ltd., Technical Information Institute Co., Ltd., and Teijin Pharma Ltd. T.K. is a former employee and stockholder of Pfizer Inc, and is a current employee of Eli Lilly and Company. S.A., S.H., F.M., and S.Y. are employees and stockholders of Pfizer Inc. N.I. and N.Y. are former employees and stockholders of Pfizer Inc. M.N. has received lecture fees from Daiichi Sankyo Co., Ltd. K.M. has received grants and personal fees from AbbVie Inc, EA Pharma Co., Ltd., Kissei Pharmaceutical Co., Ltd., Kyorin Pharmaceutical Co., Ltd., Mitsubishi Tanabe Pharma Corporation, Mochida Pharmaceutical Co., Ltd., Nipponn Kayaku Co., Ltd., Pfizer Inc, Sekisui Medical Co., Ltd., Takeda Pharmaceutical Co., Ltd.; and personal fees from Alfresa Pharma Corporation, Gilead Sciences, Inc., GlaxoSmithKline plc, Janssen Pharmaceutical K.K., JIMRO Co., Ltd., MIYARISAN Pharmaceutical Co., Ltd., Thermo Fisher Scientific Inc., and ZERIA Pharmaceutical Co., Ltd."

"Funding This work was sponsored by Pfizer Japan Inc, Tokyo, Japan."